Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Photobiomodulation therapy in keloid management: a comprehensive review

In conclusion, PBMT offers a promising, safe, and effective alternative for keloid management by targeting key fibrotic, inflammatory, and angiogenic processes.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This review examines photobiomodulation therapy, a non-invasive approach using red to near-infrared light, as a possible treatment for keloid scars. The authors report that preclinical and clinical studies showed reductions in scar size, collagen deposition, and symptoms such as pain and itching. They describe the therapy as well tolerated, but state that larger randomized controlled trials with standardized protocols are needed to confirm long-term effectiveness.

Who or what was studied
Patients with keloid scars, plus animal models and fibroblast cultures in preclinical evidence
Limits stated in the abstract
The abstract states that further large-scale randomized controlled trials with standardized protocols are needed to confirm long-term efficacy, and it does not report the number of studies or participants included.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Keloid formation is a pathological scarring process marked by excessive fibroblast activity, overproduction of extracellular matrix (ECM), and chronic inflammation, presenting significant challenges in management despite existing treatments like corticosteroid injections, surgical excision, and cryotherapy. This review evaluates Photobiomodulation Therapy (PBMT) as a promising non-invasive approach for keloid treatment. PBMT utilizes non-thermal light in the red to near-infrared spectrum, which enhances mitochondrial activity, reduces reactive oxygen species (ROS), and regulates fibroblast proliferation and apoptosis. It also exhibits anti-fibrotic properties by inhibiting TGF-β1 expression, collagen synthesis, and Smad signaling, while modulating inflammation through reduced pro-inflammatory cytokines (IL-6, TNF-α) and enhanced macrophage activity. Preclinical evidence in animal models and fibroblast cultures demonstrates PBMT's ability to reduce scar size, collagen deposition, and fibroblast activity. Clinical studies, including randomized controlled trials (RCTs) and case reports, show significant improvements in keloid height, elasticity, and texture, with reductions in pain and pruritus, as well as lower recurrence rates compared to conventional therapies. PBMT is well-tolerated with minimal adverse effects, such as transient redness or mild itching, and is safe for all skin types, including those with darker pigmentation. In conclusion, PBMT offers a promising, safe, and effective alternative for keloid management by targeting key fibrotic, inflammatory, and angiogenic processes. However, further large-scale randomized controlled trials with standardized protocols are necessary to confirm its long-term efficacy and integrate it into clinical practice.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Reactive oxygen species, Inflammation, Collagen, Near-infrared. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies